InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: commoncentsinvestor post# 7231

Sunday, 12/03/2017 6:57:36 PM

Sunday, December 03, 2017 6:57:36 PM

Post# of 8023
This enrollment in the NeoCart Phase 3 clinical trial complete, we're now preparing for the top line superiority data from this trial and the anticipated filing of the Biologic License Application or BOA in the third quarter of 2018 subject to positive Phase 3 results. This timeline leads to a potential U.S. launch as early as middle of 2019 if approved.

https://seekingalpha.com/article/4123723-histogenics-hsgx-ceo-adam-gridley-q3-2017-results-earnings-call-transcript
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News